Randomized trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/Gynecologic oncology group study

Joan L. Walker, Mark F. Brady, Lari Wenzel, Gini F. Fleming, Helen Q. Huang, Paul A. DiSilvestro, Keiichi Fujiwara, David S. Alberts, Wenxin Zheng, Krishnansu S. Tewari, David E. Cohn, Matthew A. Powell, Linda Van Le, Susan A. Davidson, Heidi J. Gray, Peter G. Rose, Carol Aghajanian, Tashanna Myers, Angeles Alvarez Secord, Stephen C. RubinRobert S. Mannel

Surgery

University of Oklahoma
Roswell Park Cancer Institute
University of California at Irvine
University of Chicago
Women and Infants Hospital of Rhode Island
Saitama Medical University
University of Arizona
Ohio State University
Washington University St. Louis
University of North Carolina at Chapel Hill
University of Colorado Anschutz Medical Campus
University of Washington
Cleveland Clinic Foundation
Memorial Sloan-Kettering Cancer Center
University of Connecticut
Duke University
University of Pennsylvania

Research output: Contribution to journal › Article › peer-review

210 Scopus citations

Sort by
Weight
Alphabetically

Randomized trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/Gynecologic oncology group study

Fingerprint

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions